DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for …
TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR
TETROUS, INC., a leading regenerative medicine company today announced that it has completed the first …
Xylyx Bio announces exclusive license agreement with Vanderbilt University for donor organ rehabilitation asset
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today …
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, …
LyGenesis Announces First Patient Dosed in its Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease
LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today …
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Today, Ajinomoto Co., Inc. (“Ajinomoto Co.”) (TSE: 2802) launched a new version of its StemFit™ iPSC …
Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma
Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue …
REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON’S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS
Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating …
